Dewpoint Therapeutics GmbH

Industry sector:Biotechnology
Products, services:Condensate drug discovery and development
Locations:Frankfurt, Dresden, Boston
Date of foundation:2018
Number of employees:150
The company:Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint
currently has programs across an ambitious pipeline spanning oncology, neurodegenerative, cardiopulmonary and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck and Pfizer. Dewpoint
scientists work to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.
Planned staff requirements:20
Area of expertise:Biochemistry, biological sciences, biotechnology, chemistry,
Additional area of expertise:Bioinformatics
Desired qualifications:PostDoc, PhD, master, students
Desired skills of applicants:Ability to communicate effectively in English, the shared language
of our multicultural team
Career opportunities:Direct entry & Internships
Trainee program (positions/year):Yes (2)